Tositumomab (I-131 labeled)
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tositumomab (I-131 labeled), covering 2018-11-15 to 2018-11-15. Get the full timeline:
Most recent: Clinical Trial Update: S0801 Iodine I 131 Tositumomab, Rituximab, and Combination Chemotherapy in Previously Untreated Stage II, Stage III, or Stage IV Follicular Non-Hodgkin Lymphoma [Phase 2]